PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
13-Oct-2021 $14.4+ Billion Erythropoietin Drugs Market Outlook, 2021-2028 | Increasing Level of Awareness About the Benefits of EPO Therapeutics - ResearchAndMarkets.com Businesswire
13-Oct-2021 $183M Microneedle Drug Delivery System Market Opportunity Assessment, 2021-2026 - ResearchAndMarkets.com Businesswire
13-Oct-2021 Scotland Becomes First Country in the World to make Digital Therapeutics for Anxiety and Insomnia Available Nationally Businesswire
13-Oct-2021 New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with Relapsing Multiple Sclerosis Businesswire
13-Oct-2021 OSE Immunotherapeutics to Present New Clinical and Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting Businesswire
13-Oct-2021 Pherecydes Pharma Publishes Its Half-year 2021 Financial Results and Assesses Its Positive Development Momentum Businesswire
13-Oct-2021 New Data up to 8-Years for Genentech’s Ocrevus (ocrelizumab) Show Early and Ongoing Treatment Significantly Reduced Risk of Requiring a Walking Aid in Relapsing Multiple Sclerosis and Disability Progression in Primary Progressive Multiple Sclerosis Businesswire
13-Oct-2021 Bicycle Therapeutics Announces Pricing of Upsized Public Offering of $175 Million of American Depositary Shares Businesswire
13-Oct-2021 百濟神州宣布,BRUKINSA® (Zanubrutinib)獲准用於治療被套細胞淋巴瘤患者 Businesswire
13-Oct-2021 百济神州宣布,百悦泽®(泽布替尼)获准用于治疗套细胞淋巴瘤患者 Businesswire
13-Oct-2021 百濟神州宣布,澳洲首次核准BRUKINSA® (Zanubrutinib)用於治療華氏巨球蛋白血症患者 Businesswire
13-Oct-2021 百济神州宣布,澳大利亚首次核准百悦泽®(泽布替尼)用于治疗华氏巨球蛋白血症患者 Businesswire
12-Oct-2021 Revance Continues to Anticipate FDA Approval of DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines in 2021 Businesswire
12-Oct-2021 Charles River Laboratories Announces Two Divestitures Businesswire
12-Oct-2021 Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annual Congress Businesswire
12-Oct-2021 Inogen Appoints Stanislav Glezer as Chief Technology Officer Businesswire
12-Oct-2021 Model N Announces Date of Fourth Quarter and Fiscal Year 2021 Financial Results Businesswire
12-Oct-2021 i2O Therapeutics Announces the Appointment of Kurt C. Graves as Executive Chairman Businesswire
12-Oct-2021 CEO Lloyd Dean Will Retire From CommonSpirit Health Next Year Businesswire
12-Oct-2021 Quantum Dot Market with COVID-19 Impact Analysis by Material, Product, Vertical and Geography - Global Forecast to 2026 - ResearchAndMarkets.com Businesswire